Michael D. Seidman
Research Subjects
Research Interests
Michael D. Seidman has a total of 128 co-authors. Here are the top co-authors by number of shared publications:
Nadir Ahmad
Department of Otolaryngology–Head & Neck Surgery Virginia Commonwealth University Richmond Virginia USA
4 shared publicationsSeilesh Babu
Department of Otology, Neurotology, & Skull Base Surgery, Michigan Ear Institute, Farmington Hills, MI48334, USA; Ascension Macomb Otolaryngology Residency, 11800 East 12 Mile Road, Warren, MI48093, USA; Department of Otolaryngology, Wayne State University, Detroit, MI, USA
3 shared publicationsCory J. Rubin
Department of Dermatology University of Michigan Ann Arbor Michigan USA
2 shared publications- Folashade Omole
Morehouse School of Medicine
2 shared publications - Jesse M. Hackell
Pomona Pediatrics, Pomona, New York, USA
2 shared publications - Marilene B. Wang
Department of Head and Neck Surgery, University of California, Los Angeles, Los Angeles, California, USA
2 shared publications
Latest Publications
- Open Access
- 22 July 2026
- Published by Springer Nature
- p. 701-713
Pulsatile Tinnitus, Tonal Tinnitus, and Hyperacusis
Tinnitus and hyperacusis can be both common and debilitating. While research has provided insight into the pathophysiology, diagnosis, and treatment of these phenomena, many questions still remain. This chapter summarizes our current understanding of tinnitus and hyperacusis.
- 22 July 2026
- Published by Springer Nature
- p. 701-713
Open AccessPulsatile Tinnitus, Tonal Tinnitus, and Hyperacusis
Tinnitus and hyperacusis can be both common and debilitating. While research has provided insight into the pathophysiology, diagnosis, and treatment of these phenomena, many questions still remain. This chapter summarizes our current understanding of tinnitus and hyperacusis.
- Open Access
- 5 May 2026
- Published by Wiley in The Laryngoscope
- Vol. 136 (10) , 4474-4481
Multi‐Frequency Electrocochleography Results in Fewer Drop Alarms During Cochlear Implant Insertion
Objective: To evaluate intracochlear electrocochleography (ECochG) amplitude parameters during cochlear implantation (CI) using a novel multi‐frequency ECochG algorithm. Methods: A multi‐institutional, prospective cohort study was performed at 18 high‐volume CI centers. The inclusion criteria were adults with sensorineural hearing loss and audiometric thresholds of ≤ 90 dB hearing level at 500 Hz undergoing CI with Advanced Bionics (Valencia, CA) Ultra 3D devices between 2024 and 2025. ECochG recordings were performed with simultaneous multi‐frequency stimulation of four frequencies between 125 and 4000 Hz during cochlear implant insertion. Concurrent multi‐frequency recording allowed extraction of amplitude and phase of each frequency individually. Post hoc analysis was performed to determine the difference in the number of drop alarms between single‐ and multi‐frequency ECochG. An ECochG amplitude drop of 6 dB was defined as a drop alarm. Insertion track patterns were compared between single‐ and multi‐frequency ECochG. Results: One hundred ninety‐five ears were included. Mean number of drop alarms for the single‐frequency algorithm was 1.72 (95% CI: 1.52, 1.92; median 1) compared to 0.42 (95% CI: 0.31, 0.53; median 0) for multi‐frequency; p < 0.001. The number of Type C patterns (rise in amplitude during insertion followed by a drop) decreased with the multi‐frequency ECochG algorithm compared to the single‐frequency ECochG algorithm. The number of Type D patterns (no‐response) decreased, indicating that multi‐frequency ECochG generated more responses across the cochlea than single‐frequency ECochG. Conclusions: A novel multi‐frequency ECochG algorithm during CI is associated with fewer drop alarms and altered insertion track patterns, which may provide a more accurate assessment of the cochlear microenvironment. Level of Evidence: 3.
- 5 May 2026
- Published by Wiley in The Laryngoscope
- Vol. 136 (10) , 4474-4481
Open AccessMulti‐Frequency Electrocochleography Results in Fewer Drop Alarms During Cochlear Implant Insertion
Objective: To evaluate intracochlear electrocochleography (ECochG) amplitude parameters during cochlear implantation (CI) using a novel multi‐frequency ECochG algorithm. Methods: A multi‐institutional, prospective cohort study was performed at 18 high‐volume CI centers. The inclusion criteria were adults with sensorineural hearing loss and audiometric thresholds of ≤ 90 dB hearing level at 500 Hz undergoing CI with Advanced Bionics (Valencia, CA) Ultra 3D devices between 2024 and 2025. ECochG recordings were performed with simultaneous multi‐frequency stimulation of four frequencies between 125 and 4000 Hz during cochlear implant insertion. Concurrent multi‐frequency recording allowed extraction of amplitude and phase of each frequency individually. Post hoc analysis was performed to determine the difference in the number of drop alarms between single‐ and multi‐frequency ECochG. An ECochG amplitude drop of 6 dB was defined as a drop alarm. Insertion track patterns were compared between single‐ and multi‐frequency ECochG. Results: One hundred ninety‐five ears were included. Mean number of drop alarms for the single‐frequency algorithm was 1.72 (95% CI: 1.52, 1.92; median 1) compared to 0.42 (95% CI: 0.31, 0.53; median 0) for multi‐frequency; p < 0.001. The number of Type C patterns (rise in amplitude during insertion followed by a drop) decreased with the multi‐frequency ECochG algorithm compared to the single‐frequency ECochG algorithm. The number of Type D patterns (no‐response) decreased, indicating that multi‐frequency ECochG generated more responses across the cochlea than single‐frequency ECochG. Conclusions: A novel multi‐frequency ECochG algorithm during CI is associated with fewer drop alarms and altered insertion track patterns, which may provide a more accurate assessment of the cochlear microenvironment. Level of Evidence: 3.
- 1 September 2024
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 45 (8) , 863-869
Artificial Intelligence for Diagnosis in Otologic Patients: Is It Ready to Be Your Doctor?
Objective: Investigate the precision of language-model artificial intelligence (AI) in diagnosing conditions by contrasting its predictions with diagnoses made by board-certified otologic/neurotologic surgeons using patient-described symptoms. Study Design: Prospective cohort study. Setting: Tertiary care center. Patients: One hundred adults participated in the study. These included new patients or established patients returning with new symptoms. Individuals were excluded if they could not provide a written description of their symptoms. Interventions: Summaries of the patient's symptoms were supplied to three publicly available AI platforms: Chat GPT 4.0, Google Bard, and WebMD “Symptom Checker.” Main Outcome Measures: This study evaluates the accuracy of three distinct AI platforms in diagnosing otologic conditions by comparing AI results with the diagnosis determined by a neurotologist with the same information provided to the AI platforms and again after a complete history and physical examination. Results: The study includes 100 patients (52 men and 48 women; average age of 59.2 yr). Fleiss' kappa between AI and the physician is −0.103 (p < 0.01). The chi-squared test between AI and the physician is χ 2 = 12.95 (df = 2; p < 0.001). Fleiss' kappa between AI models is 0.409. Diagnostic accuracies are 22.45, 12.24, and 5.10% for ChatGPT 4.0, Google Bard, and WebMD, respectively. Conclusions: Contemporary language-model AI platforms can generate extensive differential diagnoses with limited data input. However, doctors can refine these diagnoses through focused history-taking, physical examinations, and clinical experience—skills that current AI platforms lack.
- 1 September 2024
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 45 (8) , 863-869
Artificial Intelligence for Diagnosis in Otologic Patients: Is It Ready to Be Your Doctor?
Objective: Investigate the precision of language-model artificial intelligence (AI) in diagnosing conditions by contrasting its predictions with diagnoses made by board-certified otologic/neurotologic surgeons using patient-described symptoms. Study Design: Prospective cohort study. Setting: Tertiary care center. Patients: One hundred adults participated in the study. These included new patients or established patients returning with new symptoms. Individuals were excluded if they could not provide a written description of their symptoms. Interventions: Summaries of the patient's symptoms were supplied to three publicly available AI platforms: Chat GPT 4.0, Google Bard, and WebMD “Symptom Checker.” Main Outcome Measures: This study evaluates the accuracy of three distinct AI platforms in diagnosing otologic conditions by comparing AI results with the diagnosis determined by a neurotologist with the same information provided to the AI platforms and again after a complete history and physical examination. Results: The study includes 100 patients (52 men and 48 women; average age of 59.2 yr). Fleiss' kappa between AI and the physician is −0.103 (p < 0.01). The chi-squared test between AI and the physician is χ 2 = 12.95 (df = 2; p < 0.001). Fleiss' kappa between AI models is 0.409. Diagnostic accuracies are 22.45, 12.24, and 5.10% for ChatGPT 4.0, Google Bard, and WebMD, respectively. Conclusions: Contemporary language-model AI platforms can generate extensive differential diagnoses with limited data input. However, doctors can refine these diagnoses through focused history-taking, physical examinations, and clinical experience—skills that current AI platforms lack.
- 11 October 2022
- Published by Elsevier in Otolaryngologic Clinics of North America
- Vol. 55 (5)
Complementary and Integrative Medicine and Nutrition in Otolaryngology
- 11 October 2022
- Published by Elsevier in Otolaryngologic Clinics of North America
- Vol. 55 (5)
Complementary and Integrative Medicine and Nutrition in Otolaryngology
- 19 September 2022
- Published by Elsevier in Otolaryngologic Clinics of North America
- Vol. 55 (5) , XVII-XVIII
Complementary Integrative Medicine, Health, and Wellness: A Guide for the Otolaryngologist
- 19 September 2022
- Published by Elsevier in Otolaryngologic Clinics of North America
- Vol. 55 (5) , XVII-XVIII
Complementary Integrative Medicine, Health, and Wellness: A Guide for the Otolaryngologist
- 8 September 2022
- Published by Elsevier in Otolaryngologic Clinics of North America
- Vol. 55 (5) , 1101-1110
Endocannabinoid System and the Otolaryngologist
- 8 September 2022
- Published by Elsevier in Otolaryngologic Clinics of North America
- Vol. 55 (5) , 1101-1110
Endocannabinoid System and the Otolaryngologist
- 7 September 2022
- Published by Elsevier in Otolaryngologic Clinics of North America
- Vol. 55 (5) , 1035-1044
Natural Alternatives and the Common Cold and Influenza
- 7 September 2022
- Published by Elsevier in Otolaryngologic Clinics of North America
- Vol. 55 (5) , 1035-1044
Natural Alternatives and the Common Cold and Influenza
- 7 September 2022
- Published by Elsevier in Otolaryngologic Clinics of North America
- Vol. 55 (5) , 899-907
Healthy Aging
- 7 September 2022
- Published by Elsevier in Otolaryngologic Clinics of North America
- Vol. 55 (5) , 899-907
Healthy Aging
- 1 August 2020
- Published by Elsevier in Otolaryngologic Clinics of North America
- Vol. 53 (4) , 637-650
Alternative Treatments of Tinnitus
- 1 August 2020
- Published by Elsevier in Otolaryngologic Clinics of North America
- Vol. 53 (4) , 637-650
Alternative Treatments of Tinnitus
- Open Access
- 21 May 2020
- Published by SAGE Publications in Ear, Nose & Throat Journal
- Vol. 100 (10) , NP444-NP453
A Basis for Standardizing Superior Semicircular Canal Dehiscence Management
Objectives: (1) To determine how otologic/neurotologic surgeons counsel patients with superior semicircular canal dehiscence (SSCD). (2) To understand the plethora of presenting symptoms associated with SSCD and appropriate management. (3) To suggest appropriate management; oftentimes avoiding surgery. Methods: This was a survey study of both community and academic physicians. A 23-question survey was distributed to all members of the American Neurotological (ANS) and American Otologic Societies (AOS) via email in the Fall of 2018. A total of 54 responses were received from a possible pool of 279 for a response rate of 19.4%. Inferences were made about the population through sample proportions and confidence intervals. Results: All respondents use computed tomography (CT) in diagnosing SSCD and 11.1% use CT exclusively. Cervical vestibular evoked myogenic potential (VEMP; 77.8%) are used more often than ocular VEMPs (38.9%). Magnetic resonance imaging (7.4%) is used infrequently; 96.3% of surgeons surveyed have seen patients with SSCD on imaging that are asymptomatic. Following surgical treatment, respondents reported balance issues and mild-to-moderate high-frequency sensorineural hearing loss (88.4%); 32.6% reported that the majority (>50%) of their patients needed further intervention after surgery, typically aggressive vestibular rehabilitation. Conclusions: There is a discrepancy in the systematic approach to SSCD between both the surgeons and the published literature. Patients with SSCD on ultra-high-resolution CT may have myriad symptoms while others are asymptomatic, and surgery may lead to additional complications. We will present a methodical recommendation to assist in the management of patients with SSCD depending upon their symptoms. This may improve patient selection, counseling, and outcomes.
- 21 May 2020
- Published by SAGE Publications in Ear, Nose & Throat Journal
- Vol. 100 (10) , NP444-NP453
Open AccessA Basis for Standardizing Superior Semicircular Canal Dehiscence Management
Objectives: (1) To determine how otologic/neurotologic surgeons counsel patients with superior semicircular canal dehiscence (SSCD). (2) To understand the plethora of presenting symptoms associated with SSCD and appropriate management. (3) To suggest appropriate management; oftentimes avoiding surgery. Methods: This was a survey study of both community and academic physicians. A 23-question survey was distributed to all members of the American Neurotological (ANS) and American Otologic Societies (AOS) via email in the Fall of 2018. A total of 54 responses were received from a possible pool of 279 for a response rate of 19.4%. Inferences were made about the population through sample proportions and confidence intervals. Results: All respondents use computed tomography (CT) in diagnosing SSCD and 11.1% use CT exclusively. Cervical vestibular evoked myogenic potential (VEMP; 77.8%) are used more often than ocular VEMPs (38.9%). Magnetic resonance imaging (7.4%) is used infrequently; 96.3% of surgeons surveyed have seen patients with SSCD on imaging that are asymptomatic. Following surgical treatment, respondents reported balance issues and mild-to-moderate high-frequency sensorineural hearing loss (88.4%); 32.6% reported that the majority (>50%) of their patients needed further intervention after surgery, typically aggressive vestibular rehabilitation. Conclusions: There is a discrepancy in the systematic approach to SSCD between both the surgeons and the published literature. Patients with SSCD on ultra-high-resolution CT may have myriad symptoms while others are asymptomatic, and surgery may lead to additional complications. We will present a methodical recommendation to assist in the management of patients with SSCD depending upon their symptoms. This may improve patient selection, counseling, and outcomes.